М. В. Сидорова

1.2k total citations
112 papers, 961 citations indexed

About

М. В. Сидорова is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, М. В. Сидорова has authored 112 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 17 papers in Pharmacology. Recurrent topics in М. В. Сидорова's work include Neuropeptides and Animal Physiology (20 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (16 papers) and Apelin-related biomedical research (16 papers). М. В. Сидорова is often cited by papers focused on Neuropeptides and Animal Physiology (20 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (16 papers) and Apelin-related biomedical research (16 papers). М. В. Сидорова collaborates with scholars based in Russia, British Virgin Islands and Brazil. М. В. Сидорова's co-authors include А. С. Молокоедов, M.V. Ovchinnikov, С. В. Гнеденков, О. И. Писаренко, Sergey L. Sinebryukhov, И. М. Студнева, Dmitry V. Mashtalyar, В. С. Егоркин, L. I. Serebryakova and Valery Shako and has published in prestigious journals such as FEBS Letters, International Journal of Molecular Sciences and Corrosion Science.

In The Last Decade

М. В. Сидорова

102 papers receiving 914 citations

Peers

М. В. Сидорова
М. В. Сидорова
Citations per year, relative to М. В. Сидорова М. В. Сидорова (= 1×) peers Martin Robitaille

Countries citing papers authored by М. В. Сидорова

Since Specialization
Citations

This map shows the geographic impact of М. В. Сидорова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. В. Сидорова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. В. Сидорова more than expected).

Fields of papers citing papers by М. В. Сидорова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М. В. Сидорова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. В. Сидорова. The network helps show where М. В. Сидорова may publish in the future.

Co-authorship network of co-authors of М. В. Сидорова

This figure shows the co-authorship network connecting the top 25 collaborators of М. В. Сидорова. A scholar is included among the top collaborators of М. В. Сидорова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. В. Сидорова. М. В. Сидорова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imshinetskiy, I.M., Dmitry V. Mashtalyar, М. В. Сидорова, et al.. (2024). Bioresorbable composites based on magnesium and hydroxyapatite for use in bone tissue engineering: Focus on controlling and minimizing corrosion activity. Ceramics International. 51(1). 423–436. 6 indexed citations
2.
Студнева, И. М., et al.. (2024). The structural analogue of apelin-12 prevents energy disorders in the heart in experimental type 1 diabetes mellitus. Biomeditsinskaya Khimiya. 70(3). 135–144.
3.
Arefieva, T. I., et al.. (2023). Biodegradable Microparticles with Encapsulated Anti-Inflammatory Peptide Ingramon. Pharmaceutical Chemistry Journal. 57(8). 1290–1297.
4.
Сидорова, М. В., M.V. Ovchinnikov, А. С. Молокоедов, et al.. (2022). Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain. Doklady Biochemistry and Biophysics. 507(1). 237–241. 1 indexed citations
5.
Сидорова, М. В., et al.. (2021). Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor. Biochemistry (Moscow) Supplement Series B Biomedical Chemistry. 15(4). 274–280. 5 indexed citations
6.
Сидорова, М. В., et al.. (2020). [MeArg1, NLe10]-apelin-12: Optimization of solid-phase synthesis and evaluation of biological properties in vitro and in vivo. Peptides. 129. 170320–170320. 8 indexed citations
7.
Serebryakova, L. I., И. М. Студнева, А. С. Молокоедов, et al.. (2018). Galanin and its N-terminal fragments reduce acute myocardial infarction in rats. Peptides. 111. 127–131. 12 indexed citations
8.
Arefieva, T. I., et al.. (2017). Cysteine-Containing Peptides Stimulate Monocyte Migration through NADPH-Oxidase Activation. Bulletin of Experimental Biology and Medicine. 163(2). 203–205. 1 indexed citations
9.
Vorotnikov, Alexander V., et al.. (2017). Impact of Atherosclerosis‐ and Diabetes‐Related Dicarbonyls on Vascular Endothelial Permeability: A Comparative Assessment. Oxidative Medicine and Cellular Longevity. 2017(1). 1625130–1625130. 13 indexed citations
10.
Сидорова, М. В., et al.. (2013). Effects of structural analogues of apelin-12 in acute myocardial infarction in rats. Journal of Pharmacology and Pharmacotherapeutics. 4(3). 198–198. 33 indexed citations
11.
Сидорова, М. В., et al.. (2012). Suppression of vascular endothelium hyperpermeability by cell-permeating peptide inhibitors of myosin light chain kinase. BIOPHYSICS. 57(5). 587–591. 3 indexed citations
12.
Сидорова, М. В., et al.. (2010). Novel peptide inhibitors of myosin light chain kinase suppress the hyperpermeability of vascular endothelium. BIOPHYSICS. 55(6). 926–930. 1 indexed citations
13.
Nikitin, Petr I., Tatiana I. Ksenevich, B. G. Gorshkov, et al.. (2010). Effect of the C-terminal domain peptide fragment (65–76) of monocytic chemotactic protein-1 (MCP-1) on the interaction between MCP-1 and heparin. Doklady Biological Sciences. 433(1). 289–292. 5 indexed citations
14.
Bashtrykov, Pavel, et al.. (2009). Effects of synthetic monocyte chemotactic protein-1 fragment 65–76 on neointima formation after carotid artery balloon injury in rats. Neuroscience and Behavioral Physiology. 39(2). 153–159. 4 indexed citations
15.
Чазов, Е. И., et al.. (2006). Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65–76 of monocyte chemotactic protein-1 (MCP-1). Doklady Biochemistry and Biophysics. 411(1). 339–341. 3 indexed citations
16.
Arefieva, T. I., et al.. (2005). The Peptide of Sequence 66–77 of Monocytic Chemotactic Protein (MCP-1) Inhibits Inflammation in Experimental Animals. Doklady Biological Sciences. 404(1-6). 402–405. 5 indexed citations
17.
Сидорова, М. В., et al.. (2004). Novel Phosphospecific Antibodies for Monitoring Phosphorylation of Proteins Encoded by the Myosin Light Chain Kinase Genetic Locus. Biochemistry (Moscow). 69(7). 789–798. 4 indexed citations
18.
Сидорова, М. В., et al.. (1997). Comparative evaluation of different methods for disulfide bond formation in synthesis of the HIV‐2 antigenic determinant. Journal of Peptide Research. 49(1). 52–58. 29 indexed citations
20.
Slepushkin, Vladimir, et al.. (1992). Investigation of Human Immunodeficiency Virus Fusion Peptides. Analysis of Interrelations Between Their Structure and Function. AIDS Research and Human Retroviruses. 8(1). 9–18. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026